Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3533

Actual shortage: 232 (7%)
Anticipated shortage: 3 (0%)
Avoided shortage: 11 (0%)
Resolved: 3287 (93%)

Discontinuation Reports

366

To be discontinued: 24 (7%)
Discontinued: 342 (93%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

32 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TRI-CIRA 21 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG TABLET Resolved 2023-04-06 2023-08-12 188979
TRI-CIRA 21 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG TABLET Resolved 2024-01-05 2024-02-02 215236
TRI-CIRA 28 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG TABLET Resolved 2023-03-23 2023-08-12 187715
TRI-CIRA LO 21 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG TABLET Resolved 2022-02-22 2022-03-07 155371
TRI-CIRA LO 21 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG TABLET Resolved 2022-10-28 2023-04-14 172942
TRI-CIRA LO 21 0.18MG 0.025MG 0.025MG 0.25MG 0.025MG 0.215MG TABLET Resolved 2025-07-31 2025-08-15 263987
TRI-CIRA LO 21 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2018-01-18 2018-02-23 36429
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2018-12-27 2019-01-23 70526
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-03-05 2019-05-21 77902
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-03-13 2019-05-21 78558
TRI-CIRA LO 21 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-04-10 2019-08-26 80931
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-08-07 2019-08-26 91109
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-11-13 2019-11-18 98575
APO-TRIMEBUTINE 100MG TABLET Resolved 2021-11-24 2021-12-24 149793
APO-TRIMEBUTINE 100MG TABLET Resolved 2023-02-03 2023-04-17 183589
APO-TRIMEBUTINE 100MG TABLET Resolved 2023-07-14 2023-08-14 198716
ZAMINE 21 3.0MG 0.030MG TABLET Resolved 2017-03-11 2020-09-04 558
ZAMINE 21 0.03MG 3MG TABLET Resolved 2023-06-16 2023-07-27 195081
ZAMINE 21 0.03MG 3MG TABLET Resolved 2023-11-17 2023-12-22 210668
ZAMINE 21 0.03MG 3MG TABLET Resolved 2024-02-02 2024-03-29 218391

Showing 3501 to 3520 of 3533

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LOSARTAN/HCTZ 25MG 100MG TABLET Discontinued 2018-09-10 2018-12-28 60997
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-11-19 2018-11-19 67146
APO-LOSARTAN/HCTZ 12.5MG 50MG TABLET Discontinued 2019-01-03 2019-01-03 71101
APO-MELOXICAM 7.5MG TABLET Discontinued 2018-09-07 2018-09-15 60612
APO-MEMANTINE 10MG TABLET Discontinued 2018-09-07 2018-09-15 60615
APO-METFORMIN 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40781
APO-METFORMIN 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40784
APO-METFORMIN 500MG TABLET Discontinued 2018-02-23 2018-11-26 40790
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2019-06-12 40778
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2018-09-15 40796
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Discontinued 2019-01-04 2019-01-04 71207
APO-METOCLOP TAB 10MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1101
APO-METOCLOP TAB 5MG 5mg tablet Discontinued 2017-03-13 2017-03-13 1105
APO-METOPROLOL 25MG TABLET To be discontinued 2018-09-07 2021-06-03 60628
APO-MYCOPHENOLATE 250MG CAPSULE Discontinued 2018-09-07 2018-09-15 60637
APO-MYCOPHENOLATE 500MG TABLET Discontinued 2018-09-07 2018-10-12 60640
APO-NAPRO-NA 275MG TABLET Discontinued 2018-09-08 2018-09-15 60657
APO-NAPRO-NA DS 550MG TABLET Discontinued 2018-09-08 2018-09-15 60660
APO-NAPROXEN 250MG TABLET Discontinued 2018-09-08 2018-09-15 60666
APO-NEVIRAPINE XR 400MG TABLET (EXTENDED-RELEASE) Discontinued 2019-03-11 2019-03-11 78257

Showing 221 to 240 of 366